APA
Barritt A. S., Gitlin N., Klein S., Lok A. S., Loomba R., Malahias L., Powell M., Vos M. B., Weiss L. M., Cusi K., Neuschwander-Tetri B. A. & Sanyal A. (20180713). Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study. : Contemporary clinical trials.
Chicago
Barritt A S, Gitlin Norman, Klein Samuel, Lok Anna S, Loomba Rohit, Malahias Laura, Powell Margaret, Vos Miriam B, Weiss L Michael, Cusi Kenneth, Neuschwander-Tetri Brent A and Sanyal Arun. 20180713. Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study. : Contemporary clinical trials.
Harvard
Barritt A. S., Gitlin N., Klein S., Lok A. S., Loomba R., Malahias L., Powell M., Vos M. B., Weiss L. M., Cusi K., Neuschwander-Tetri B. A. and Sanyal A. (20180713). Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study. : Contemporary clinical trials.
MLA
Barritt A S, Gitlin Norman, Klein Samuel, Lok Anna S, Loomba Rohit, Malahias Laura, Powell Margaret, Vos Miriam B, Weiss L Michael, Cusi Kenneth, Neuschwander-Tetri Brent A and Sanyal Arun. Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study. : Contemporary clinical trials. 20180713.